Anti-EpCAM scFv gadolinium chelate: a novel targeted MRI contrast agent for imaging of colorectal cancer.
Kannika KhantasupPairash SaiviroonpornSuwatchai JarussophonWarangkana ChantimaTararaj DharakulPublished in: Magma (New York, N.Y.) (2018)
The potential benefit of this contrast agent for in vivo MR imaging of colorectal cancer, as well as other EpCAM positive cancers, is suggested and warrants further investigation.